GRAIL LLC
PANAMA CITY BEACH, FLORIDA

GRAIL LLC is a company specializing in cancer detection. Incorporated on June 22, 2017, and based in Panama City Beach, FL, with a mailing address at 230 Skyline Trail, Pell City, AL, GRAIL is recognized for its advanced innovations in cancer diagnostics. The company's leadership comprises eminent individuals such as Jennifer Cook, the Chief Executive Officer, whose previous role as Head of Clinical Operations at Roche Pharmaceuticals involved managing over 400 clinical trials with significant global impact. Ken Drazan, MD, serves as President and brings over a decade of experience from his tenure at Johnson & Johnson. The company's R&D efforts are spearheaded by Dr. Alex Aravanis, known for his role in developing Illumina’s products focusing on RNA and DNA analysis. GRAIL is committed to quality, with Julie Ballard overseeing CLIA Quality and Operations, ensuring the compliance and efficacy of diagnostic tools. GRAIL employs a comprehensive team with diverse expertise including Charlotte Arnold who leads Corporate Communications after gaining valuable experience at Genentech, and Anne-Renee Hartman, MD, expert in Clinical Development from Myriad Genetics. Its technological advancements are supported by Angela Lai's software development proficiency gained from her tenure as Vice President at Google. Additionally, GraIL benefits from the regulatory acumen of Elizabeth Mansfield, PhD, who previously contributed to FDA's policy development for personalized medicine. GRAIL's incorporation status reflects a Florida Association that filed under number L17000136159 with an annual report issued on February 10, 2024. The company’s outreach is facilitated through their website grail.com and can be contacted at (650) 542-0372. GRAIL continues its mission to revolutionize cancer detection, empowered by a dedicated leadership team focused on innovative healthcare solutions.